West Pharmaceutical Services' GAAP net income for the six months of 2021 was $338.5 million, having doubled from $165.5 million in the previous year. Revenue increased 36.8% to $1.394 billion from $1.019 billion a year earlier.
West Pharmaceutical Services' GAAP net income for the six months of 2021 was $338.5 million, having doubled from $165.5 million in the previous year. Revenue increased 36.8% to $1.394 billion from $1.019 billion a year earlier. 
investor.westpharma.com
English (US) 